INS and myeloid sarcoma: Without treatment and prevention of these disorders, they would go over to prediabetes that is characterized by decreased insulin sensitivity and then, in accordance with the adverse scenario, to overt Type 2 diabetes mellitus (T2DM) and metabolic syndrome (MS) commonly associated with cardiovascular, nervous, endocrine and other diseases.